Dr. Wolpin is appointed as the new Director of the Gastrointestinal Cancer Center.
Dr. Wolpin is appointed as the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute.
Drs. Hahn and Aguirre published in Cell Rep that the ATXN1L-CIC-ETS transcription factor axis modulates sensitivity to MAPK pathway inhibition (Wang B, et al., ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition. Cell Rep. 2017;18(6):1543-57.).